Rchr
J-GLOBAL ID:200901055465486977   Update date: Apr. 05, 2024

Kawamori Dan

カワモリ ダン | Kawamori Dan
Affiliation and department:
Research field  (2): Metabolism and endocrinology ,  Internal medicine - General
Research keywords  (6): 内科学一般 ,  内分泌学 ,  代謝学 ,  Internal Medicine ,  Endocrinology ,  Metabolism
Research theme for competitive and other funds  (6):
  • 2021 - 2024 新規治療戦略を見据えた膵α細胞機能とDPP-4発現の病態学的解析
  • 2018 - 2021 A trial for efficient transdifferentiation toward pancreatic beta cells
  • 2018 - 2021 Pathophysiological analyses of functional subtypes in pancreatic alpha-cells
  • 2015 - 2018 Functional recovery of daibetic beta cells and the attempt for generating functional beta cells
  • 2014 - 2017 Pathophysiological analyses of glucagon dysregulation in development of glucose intolerance and diabetes.
Show all
Papers (92):
  • Dan Kawamori, Shugo Sasaki. Newly discovered knowledge pertaining to glucagon and its clinical applications. Journal of Diabetes Investigation. 2023. 14. 7. 829-837
  • Tsuguka Matsuda, Natsumi Himeno, Akira Nakashima, Naoya Nakagawa, Toshihiko Kohashi, Dan Kawamori, Nozomu Kamei. Different post-pancreatectomy glucagon responses to a meal test between surgical approaches. Endocrine Journal. 2023
  • Tomonori Okita, Shunbun Kita, Shiro Fukuda, Keita Fukuoka, Emi Kawada-Horitani, Masahito Iioka, Yuto Nakamura, Yuya Fujishima, Hitoshi Nishizawa, Dan Kawamori, et al. Soluble T-cadherin promotes pancreatic β-cell proliferation by upregulating Notch signaling. iScience. 2022. 25. 11. 105404-105404
  • Daisuke Yabe, Dan Kawamori, Yusuke Seino, Tomonori Oura, Masakazu Takeuchi. Change of pharmacodynamics parameters following once-weekly tirzepatide treatment versus dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono sub-study). Diabetes, obesity & metabolism. 2022. 25. 2. 398-406
  • Dan Kawamori, Yoko Kageyama, Takayuki Tanaka, Yuko Ishizaka, Shigero Hosoe, Naoto Katakami, Iichiro Shimomura. Characteristic changes in plasma glutamate levels and free amino acid profiles in Japanese patients with type 1 diabetes mellitus. Journal of Diabetes Investigation. 2022. 14. 1. 111-121
more...
MISC (43):
  • 矢部 大介, 河盛 段, 清野 祐介, 大浦 智紀, 竹内 雅和. 日本人2型糖尿病患者におけるGIP/GLP-1受容体作動薬チルゼパチドの食後代謝パラメータ、血糖変動及び体組成への影響. 糖尿病. 2022. 65. Suppl.1. S-136
  • 下直樹, 松岡孝昭, 河盛段, 宮塚健, 小山佳久, 島田昌一, 下村伊一郎. 高血糖下Tmem163抑制による膵β細胞障害. 糖尿病(Web). 2021. 64. Suppl
  • 下直樹, 松岡孝昭, 河盛段, 宮塚健, 小山佳久, 島田昌一, 下村伊一郎. 膵β細胞高血糖毒性感受性遺伝子Tmem163の解析. 糖尿病(Web). 2020. 63. Suppl
  • Smart insulin. 2017. 44. 2. 114-118
  • Exploring the molecular mechanisms underlying α- and β-cell dysfunction in diabetes. Diabetology international. 2017. 8. 3. 248-256
more...
Education (2):
  • - 2004 大阪大学大学院 医学系研究科
  • - 1996 Osaka University Faculty of Medicine Medical School
Professional career (1):
  • 医学博士
Work history (10):
  • 2020/06 - 現在 Osaka University Hospital
  • 2020/06 - 現在 Osaka University Faculty of Medicine Medical School
  • 2010/09 - 現在 Osaka University Graduate School of Medicine
  • 2017/10 - 2020/05 Osaka University Medical School, Faculty of Medicine
  • 2014/08 - 2017/09 Osaka University Medical School, Faculty of Medicine
Show all
Awards (7):
  • 2017/05 - 日本糖尿病学会 リリー賞
  • 2010/06 - The Endocrine Society ENDO2010 92nd Annual Meeting Presidential Poster Competition Winner
  • 2010/04 - Keystone Symposia Barrie Hesp Scholarship
  • 2008/06 - American Diabetes Association 68th Scientific Meeting Travel Grant Awards to young investigators
  • 2007/09 - Juvenile Diabetes Research Foundation Post-doctoral Fellowship
Show all
Association Membership(s) (4):
THE JAPAN SOCIETY FOR MEDICAL EDUCATION ,  The Japan Endocrine Society ,  日本糖尿病学会 ,  日本内科学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page